⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ONC News
BeOne Medicines Ltd. American Depositary Shares
BeOne Medicines、「第44 回JPモルガン・ヘルスケア・カンファレンス」でオンコロジー分野におけるグローバルリーダーシップを強調
businesswire.com
ONC
A BeOne Medicines destaca sua liderança global em oncologia na 44 ª Conferência Anual de Saúde da J.P. Morgan
businesswire.com
ONC
BeOne Medicines destaca su liderazgo global en oncología en la 44. a Conferencia Anual de Salud de J.P. Morgan
businesswire.com
ONC
BeOne Medicines evidenzia la leadership oncologica globale alla 44 a Annual Healthcare Conference di J.P. Morgan
businesswire.com
ONC
BeOne Medicines demonstriert seine globale Marktführerschaft im Bereich Onkologie auf der 44. jährlichen J.P. Morgan Healthcare Conference
businesswire.com
ONC
BeOne Medicines met en avant son leadership mondial en oncologie lors de la 44 e J.P. Morgan Healthcare Conference annuelle
businesswire.com
ONC
BeOne Medicines亮相第44屆J.P. Morgan醫療健康大會，彰顯全球腫瘤領域領導地位
businesswire.com
ONC
BeOne Medicines benadrukt wereldwijd leiderschap in de oncologie tijdens de 44 e jaarlijkse J.P. Morgan Healthcare Conference
businesswire.com
ONC
BeOne Medicines Highlights Global Oncology Leadership at 44 th Annual J.P. Morgan Healthcare Conference
businesswire.com
ONC
ZIIHERA+TEVIMBRA+化学療法：HER2陽性進行GEAの一次治療における新たな標準となる可能性
businesswire.com
ONC